---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-036150"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:57:07.902210+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q2 net loss $3.6M ($0.24/sh); revenue $30.3M up 3% YoY; guidance reaffirmed

## Summary
- Net loss $3.6M ($0.24 loss per share) vs net loss $320K ($0.02 loss) in Q2 2023.
- Revenue $30.3M +3% YoY; system-wide sales $129.6M +8%; comp sales +2%.
- Adjusted EBITDA $2.1M vs $3.2M; includes $1.5M litigation expense and $1.4M impairment.
- Sold 7 franchise licenses (vs 21); total clinics 960; over 10 refranchise LOIs in progress.
- 2024 guidance reiterated: system-wide sales $530-545M, mid-single digit comps, 60-75 new clinics.

## SEC filing metadata
- accession: 0001628280-24-036150
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/0001628280-24-036150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000162828024036150/jynt-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-036150
- JSON: https://secwatch.observer/filing/0001628280-24-036150.json
- Plain text: https://secwatch.observer/filing/0001628280-24-036150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.